You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 16, April 28, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Quick Uptakes
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Survival Time Doubles

Rebecca Voelker

JAMA. 1999;281:1480.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A minimally invasive procedure that delivers chemotherapy directly to cancerous cells may double survival time for adults with colon cancer that has spread to the liver, according to new findings.

The technique, chemoembolization, uses a catheter inserted through a small needle puncture in the groin to deliver chemotherapy drugs to the hepatic artery leading to the tumor. After three drugs are administered, the hepatic artery is embolized, depriving the tumor of oxygen and nutrients while it is saturated with high doses of medication. Chemoembolization, says Michael C. Soulen, MD, of the University of Pennsylvania Medical Center, "homes in on the cancerous cells that have spread to the liver and avoids exposing the rest of the body to chemotherapy's toxic effects."

In a study Soulen presented last month at a Society of Cardiovascular and Interventional Radiology meeting in Orlando, Fla, 51 patients whose colon cancer had metastasized to the . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.